CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™
Uncategorized
Uncategorized
New Year’s resolutions 2026: Lessons from colleagues
Wow. I mean, just wow. Am I really that old?All I can think of as I sit down to share my annual New Year’s resolutions with you is that it seems like it was only a month ago that I was writing my 2025 list. You know, time flies and all. Maybe it is bec…
Uncategorized
Prompt, accurate diagnosis, treatment needed in corneal disorders
Eric Donnenfeld’s corneal health case presentations and panel discussion at OSN New York are always popular with meeting attendees and provide valuable clinical insights.The cases presented in 2025 included infectious keratitis after PRK, lagophthalmos…
Open-Angle Glaucoma Tied to Early-Onset Alzheimer’s Disease
Open-angle glaucoma is linked to an increased risk for early-onset Alzheimer’s disease in middle-aged adults, especially men, a new study shows. Medscape Medical News
Uncategorized
Vitrectomy finding its place in office-based surgical suite
Over the past decade, most ophthalmologists have become familiar with in-office cataract surgery, and more than 130 practices have begun offering the procedure.Now, vitrectomy is also emerging as an option for office-based surgery (OBS).Even before tha…
Diorasis Therapeutics Appoints Richard A. Kresch, MD, to Board of Directors
BOSTON–(BUSINESS WIRE)– #genetherapy–Diorasis Therapeutics, a Boston-based biotechnology company developing durable gene therapies for glaucoma and other ophthalmic diseases, today announced the appointment of Richard A. Kresch, MD, to its Board of …